Showing results (61-70 of 945) with videos related to

Sort By:
Pageof 95
Journal of Neuroimmunology|December 31, 1995
Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cellsP D Drew, G Franzoso, L M Carlson, et al.
The Journal of Biological Chemistry|October 24, 1998
Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-kappaB directs expression of the homing receptor BLR1 to mature B cellsI Wolf, V Pevzner, E Kaiser, et al.
Oncogene Research|January 1, 1988
Negative regulation of c-myc transcription involves myc family proteinsJ L Cleveland, M Huleihel, P Bressler, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1995
NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expressionP D Drew, G Franzoso, K G Becker, et al.
The EMBO Journal|October 1, 1993
The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sitesG Franzoso, V Bours, V Azarenko, et al.
The Journal of Biological Chemistry|February 20, 1999
IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing proteinA Chariot, F Princen, J Gielen, et al.
Molecular and Cellular Biology|June 1, 1997
The signal response of IkappaB alpha is regulated by transferable N- and C-terminal domainsK Brown, G Franzoso, L Baldi, et al.
Development (Cambridge, England)|October 25, 2000
Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegalyK U Wagner, E Claudio, E B Rucker, et al.
Transplantation|May 15, 2001
Differential NF-kappaB and IkappaB gene expression during development of cardiac allograft rejection versus CD154 monoclonal antibody-induced toleranceV Csizmadia, W Gao, S A Hancock, et al.
Cancer Research|July 23, 1999
Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivoD C Duffey, Z Chen, G Dong, et al.
Pageof 95